Evidence-based management of PAD & the diabetic foot

Eur J Vasc Endovasc Surg. 2013 Jun;45(6):673-81. doi: 10.1016/j.ejvs.2013.02.014. Epub 2013 Mar 27.

Abstract

Diabetic foot ulceration (DFU) is associated with high morbidity and mortality, and represents the leading cause of hospitalization in patients with diabetes. Peripheral arterial disease (PAD), present in half of patients with DFU, is an independent predictor of limb loss and can be difficult to diagnose in a diabetic population. This review focuses on the evidence for therapeutic strategies in the management of patients with DFU. We highlight the importance of timely referral of patients presenting with a new foot ulcer to a multidisciplinary team, which includes vascular surgeons and interventional radiologists.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cardiovascular Agents / therapeutic use
  • Combined Modality Therapy
  • Diabetic Foot / diagnosis
  • Diabetic Foot / epidemiology
  • Diabetic Foot / therapy*
  • Endovascular Procedures*
  • Evidence-Based Medicine
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Patient Care Team
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / epidemiology
  • Peripheral Arterial Disease / therapy*
  • Referral and Consultation
  • Risk Factors
  • Treatment Outcome
  • Vascular Surgical Procedures*

Substances

  • Anti-Bacterial Agents
  • Cardiovascular Agents
  • Hypoglycemic Agents